Status:
UNKNOWN
Mechanisms of Diabetic Nephropathy in Ecuador
Lead Sponsor:
Universidad Estatal de Milagro
Collaborating Sponsors:
Secretaría de Ciencia, Tecnología e Innovación (Senescyt)
PROMETEO
Conditions:
Diabetic Nephropathy
Diabetes Mellitus
Eligibility:
All Genders
21-70 years
Brief Summary
The prevalence of diabetes mellitus (DM) is increasing worldwide, suggesting that 45% of diabetics are undiagnosed. DM induces a kidney disease called diabetic nephropathy (DN) which is the largest si...
Detailed Description
1. Determinations of social, environmental and biological factor implicated in diabetic nephropathy in Ecuador Investigators will study subjects from the general population. Investigators will contact...
Eligibility Criteria
Inclusion
- adults,
- age between 21 and 70 years old,
- persons able to sign informed consent,
- diabetics without diabetic nephropathy,
- diabetic with diabetic nephropathy,
- not hospitalized,
- not suffering acute disease,
- living in their home for at least 6 months before to be contacted.
Exclusion
- subjects with acute diseases,
- subjects with not metabolic compensation,
- persons temporarily residing in the place of contact,
- younger than 21 years old,
- older than 70 years old.
Key Trial Info
Start Date :
September 15 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2022
Estimated Enrollment :
10064 Patients enrolled
Trial Details
Trial ID
NCT02237352
Start Date
September 15 2014
End Date
December 1 2022
Last Update
November 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UNEMI, Universidad Estatal de Milagro, Facultad de Ciencias de la Salud
Milagro, Guayas, Ecuador, 091050